Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lisa M Hess PhD"'
Autor:
Brian A Van Tine MD, PhD, Anders Krarup-Hansen MD, PhD, Lisa M Hess PhD, Albiruni R Abdul Razak MD, Victoria Soldatenkova MSc, Jennifer Wright MD, Se Hoon Park MD
Publikováno v:
Rare Tumors, Vol 14 (2022)
Background: Patient-reported outcomes (PROs), including health-related quality of life, are recommended to be routinely collected in clinical trials, but data are limited from trials of sarcoma patients. In this analysis, pooled PRO data are reported
Externí odkaz:
https://doaj.org/article/eeb8b1752f264cfaa1ea44fc9c3eb400
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 3, Pp 100643- (2024)
Introduction: Biomarker testing in oncology is fundamental for targeted therapy use and clinical trial participation. Factors contributing to previously identified racial disparities in biomarker testing remain unclear. This study investigated biomar
Externí odkaz:
https://doaj.org/article/a8845350d9c14bc2864dbde968b3f501
Autor:
Lisa M. Hess, PhD, Peter M. Krein, PhD, Diane Haldane, MS, Yimei Han, MS, Anthony N. Sireci, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 6, Pp 100336- (2022)
Introduction: NSCLC is a solid tumor with a growing number of actionable biomarkers that may inform treatment. Current guidelines recommend a broad, panel-based approach be taken to identify actionable markers. This retrospective study used a deident
Externí odkaz:
https://doaj.org/article/d32e156caf454ecfa2167d39ca22d157